0 (0%)		09-27 09:34
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	18.86	1-year :	22.03
Resists	First :	16.14	Second :	18.86
Pivot price	12.68
Supports	First :	12.41	Second :	10.1
MAs	MA(5) :	14.74	MA(20) :	12.28
	MA(100) :	10.84	MA(250) :	10.91
MACD	MACD :	0.9	Signal :	0.6
%K %D	K(14,3) :	70.4	D(3) :	80.7
RSI	RSI(14): 60
52-week	High :	28.68	Low :	4.11

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ FBRX ] has closed below upper band by 33.3%. Bollinger Bands are 89.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	15.14 - 15.23	15.23 - 15.29
Low:	13.41 - 13.52	13.52 - 13.6
Close:	13.69 - 13.86	13.86 - 13.98

Sun, 21 Sep 2025
Investors Purchase High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Wed, 17 Sep 2025
Forte Biosciences Reaches US$205m Market Cap Benefiting Insider Stock Buying - Sahm

Mon, 15 Sep 2025
95% NK Cell Reduction: Forte's FB102 Drug Shows Breakthrough Results in Celiac Disease Clinical Trial - Stock Titan

Sun, 14 Sep 2025
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Drop in Short Interest - MarketBeat

Wed, 20 Aug 2025
Forte Biosciences, Inc.'s (NASDAQ:FBRX) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 9.2% Over the Past Week - 富途牛牛

Sun, 03 Aug 2025
Forte Biosciences, Inc.'s (NASDAQ:FBRX) recent 17% pullback adds to one-year year losses, institutional owners may take drastic measures - simplywall.st

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	12 (M)
Shares Float	10 (M)
Held by Insiders	4.9 (%)
Held by Institutions	85.4 (%)
Shares Short	99 (K)
Shares Short P.Month	129 (K)

EPS	-3.69
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	8.02
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-40.8 %
Return on Equity (ttm)	-73.5 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-3.52
Qtrly Earnings Growth	0 %
Operating Cash Flow	-39 (M)
Levered Free Cash Flow	-23 (M)

PE Ratio	-3.77
PEG Ratio	0
Price to Book value	1.72
Price to Sales	0
Price to Cash Flow	-4.47

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.